PepSight
MUSCLE DEVELOPMENT

Follistatin 344

Follistatin 344 is a muscle development peptide used in evidence-based, physician-supervised protocols. Use for muscle development beyond plateau, sarcopenia reversal, or performance enhancement.

What is Follistatin 344?

Recombinant Follistatin 344 — endogenous myostatin inhibitor. Binds and neutralizes myostatin (GDF-8) and activin A, releasing the natural brake on muscle fiber hypertrophy. Allows satellite cell proliferation and myofiber growth beyond genetic ceiling. 3x/year cycles.

Uses & clinical decision logic

Use for muscle development beyond plateau, sarcopenia reversal, or performance enhancement. IM injection into target muscle groups preferred.

Follistatin 344 dosage & administration

Vial sizeBAC waterDosing rangeUnits / doseFrequencyRoute
1mg1mL200mcg20 units4 bottle cycle over 20 daysIM

Safety & contraindications

May accelerate growth in existing benign/malignant tumors — screen before use.

Stacking & combinations

Pairs with GH peptides (CJC/Ipa) for synergistic muscle-building effect; compatible with IGF-1 LR3 and MGF.

Related peptides

Frequently asked questions

What is Follistatin 344 used for?

Use for muscle development beyond plateau, sarcopenia reversal, or performance enhancement. IM injection into target muscle groups preferred.

What is the typical Follistatin 344 dosage?

Common dosing ranges from 200mcg (4 bottle cycle over 20 days, IM). Exact dosing is individualized and set by a licensed physician.

How is Follistatin 344 administered?

Follistatin 344 is typically administered via IM.

What are the contraindications for Follistatin 344?

May accelerate growth in existing benign/malignant tumors — screen before use.

Considering Follistatin 344?

Build a physician-supervised protocol around your goal — no gatekeeping, real doctors, 503A compounding pharmacies.

Build your protocol →

This page is for educational purposes only and is not medical advice. Peptide therapies described here are provided under physician supervision through 503A compounding pharmacies. Many peptides are not FDA-approved for the uses described. Do not start, stop, or change any protocol without consulting a licensed physician.